Top Tweets for #CVPracticeJournal
#ESCGuidelines on CVD prevention offers the SCORE2 (40 to 69 years) and #SCORE2-OP (≥ 70 years) for "apparently healthy" individuals, usable by themselves or by their health care providers. A rapid approach reviewed in #CVPracticeJournal https://t.co/EiweUTlC7x
@StefanoNistri
#AirbornePollution is present both in- & outdoors, is deleterious for the #cardiovascular system & enhances #cardiometabolic risk factors. #Exercise in strongly polluted conditions should be discouraged. Read in #CVPracticeJournal https://t.co/MoQoCC9qIm
@SchneiderAlex71
Heat exposure relates with↗️ #cardiovascular mortality & morbidity. Heat-related CV impact is predicted to↗️ due to global warming+population growth+ageing. Heat-health actions need to be implemented at multiple levels https://t.co/Vgc2NezV7c
#CVPracticeJournal
#AirPollution is a proven risk factor of #hypertension incidence & prognosis. Multiple pathophysiological mechanisms link #AirPollution & #hypertension. #AirPollution should be considered as one modifiable CV #riskfactor https://t.co/lEKeMrJE1R
#CVPracticeJournal @StefanoNistri
In healthy people aged 40-69 ys, the 10-year total #ASCVD risk is assessed by the SCORE 2 model & in those ≥70 years by SCORE 2 O.P. model with appropriate 4 subgroups of countries 👉
https://t.co/XBYcpbtO6z
#CVPracticeJournal @StefanoNistri
Inherited Cardiac Conditions (ICCs) cause arrhythmias, particularly in younger population. Evidence suggests a role of #genetic variants and polygenic risk in ICCs.
@Chiara_Scrocco @GiulioConte9 @BehrElijah in #CVPracticeJournal 👉https://t.co/D4j4l6WVbQ
@StefanoNistri
#Diabetes & #PAD are #CHD equivalents. #CTA is the preferred #cvimaging modality 2 assess/plan intervention in #PAD (surgical or endovascular) Tight control of blood sugar #BP & #hyperlipidaemia + antiplatelet therapy are key https://t.co/qHmdtNHf5s
#CVPracticeJournal
#Diabetes is a major #RiskFactor for #PeripheralArteryDisease w/⬆️morbidity/mortality. #SecondaryPrevention is needed to⬇️the risk of CV & #microvascular complications by appropriate #CareModel. @keelyspencerjns and @hannahbeba in #CVPracticeJournal https://t.co/Gd9jx1PSFe
#CABG is the preferred revascularisation modality for pts w #diabetes. #Hybridrevascularisation may be effective & safe for #diabetes patients with multivessel #CAD after a multidisciplinary Heart Team approach. Reviewed in #CVPracticeJournal by @gxBBgg https://t.co/KIAWLfBmGD
#CAD is common in diabetics often w. atypical pres demanding a⬆️index of suspicion. Attention to #ESCGuidelines-directed therapies to glycaemia, #BP & #lipids is needed, contemplating also⬆️risk of complications. #CVPracticeJournal by @ProfessorRajeev https://t.co/4Y4Rs7Cw1K
The editors of the #CVPracticeJournal are currently preparing a special series on pollution/climate change as a #RiskFactor for #HeartDisease
Will you contribute? Here are all the details: https://t.co/OsqbgH1tFf 😊
#cardiotwitter #medtwitter
#QTc prolongation is common in pts with #diabetes
who are at⬆️risk of #SCD. #QTc prolongation is multifactorial though #glucose control is key
#QTc-prolonging medication should be prescribed with caution. Summarized by @drdompimenta in #CVPracticeJournal https://t.co/yZq0Jx30BV
#ESCguidelines indicate the need to identify causes of #HF 'cause of disease-specific treatments. Most #cardiomyopathies and #phenocopies are heritable genetic diseases: precise diagnosis is mandatory especially when affects treatments
https://t.co/jYnoME7EFA
#CVPracticeJournal
#NonAdherence is a major factor for suboptimal #BP control. A one-size-fits-all approach is not ideal. A personalised approach is needed to address it. @spoorthy_burli in #CVPracticeJournal https://t.co/mm1Tjd8fPT
@HeartOTXHeartMD @iamritu @AnastasiaSMihai @KreutzReinhold
@AnastasiaSMihai @escardio @ESC_Journals @ESC_Lavinia @ESC_Camille @Steph_Achenbach @VDelgadoGarcia @Barbara_Casadei #CVPracticeJournal reaches >40000 cardiologists and is read by most of them. Of course no IF nor other metrics....but it arrives to clinicians, it is quick, easy and effectively conveys important messages. Thank you for contributing 🙏
Pleasing to see our paper for @escardio @ESC_Journals #CVPracticeJournal continues to promote discussion @StefanoNistri @ESC_Lavinia @ESC_Camille @Steph_Achenbach @VDelgadoGarcia @Barbara_Casadei
Hopefully it will bring change to clinical practice🙏
Interesting figure by @DrMarthaGulati . I’m convinced since the beginning that « one size doesn’t fit all ». Another issue is that we don’t prescribe according to the weight in adults whereas we have precise mg /kg for children and teens. The same for ethnicity as…
@DrMarthaGulati @AnastasiaSMihai @MaasAngela Thank you all.
The #CouncilforCardiologyPractice is sensitive to such important issues. And I am sure that #CVPracticeJournal is interested in the whole topic of sex-related problems in CV care, that you 3 master so accurately. 🙏 @ESC_Lavinia
This is the 3 paper of a cluster of articles dedicated y #CVPracticeJournal addressing multiple aspects of hypertension
This latter paper focuses on the specific gender related issues regarding noncompliance. Thank you @AnastasiaSMihai @DrMarthaGulati @MaasAngela
Non-compliance in #antihypertensive Tx is more challenging for ♀️ than for men ♂️. Barriers include pt motivation, #HealthSystem factors & clinical inertia that must be addressed together. @AnastasiaSMihai @DrMarthaGulati @MaasAngela in #CVPracticeJournal https://t.co/F0eplnHfd1
Non-compliance in #antihypertensive Tx is more challenging for ♀️ than for men ♂️. Barriers include pt motivation, #HealthSystem factors & clinical inertia that must be addressed together. @AnastasiaSMihai @DrMarthaGulati @MaasAngela in #CVPracticeJournal https://t.co/F0eplnHfd1
@AnastasiaSMihai @vass_vassiliou @DrMarthaGulati @MaasAngela @DBelardoMD @escardio @SilCastelletti @ASPCardio @KTamirisaMD @iamritu @khurramn1 @rblument1 @netta_doc @dranulala That's it. Persistence is a problem particularly in situations in which symptoms are absent. Education not only information is hugely needed
#CVPracticeJournal
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
240.2M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
109M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.3M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.6M followers
KATY PERRY
@katyperry
86.8M followers
Taylor Swift
@taylorswift13
80.6M followers
Lady Gaga
@ladygaga
72.2M followers
Kim Kardashian
@kimkardashian
69.4M followers
YouTube
@youtube
68.6M followers
Virat Kohli
@imvkohli
68.6M followers
Bill Gates
@billgates
63.4M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
61.1M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
59.9M followers